Recent Updates
Recently added Catalysts
ZYME

Zymeworks Announces Presentations At 2022 American Society Of Clinical Oncology (ASCO) Annual Meeting

Key Takeaway: Zymeworks Announces Presentations At 2022 American Society Of Clinical Oncology (ASCO) Annual Meeting
Price reaction · baseline $4.82 (2022-04-26 close) · hit after-hours · 2 other ZYME headline(s) in the window, move may be shared
day 0 close
+0.8%

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+23%
120-day peak, hindsight
Typical move
5.4%
average across 7 past catalysts
Cash runway
~35 mo
Minimal dilution risk
Lead asset
ZW49
Phase 1 · HER2-expressing Cancers

Full Press Release Details

Zymeworks Announces Presentations At 2022 American Society Of Clinical Oncology (ASCO) Annual Meeting.
Last updated: Apr 27, 2022